Cost effectiveness of lopinavir/ritonavir compared with atazanavir plus ritonavir in antiretroviral-experienced patients in the US.

Cost effectiveness of lopinavir/ritonavir compared with atazanavir plus ritonavir in antiretroviral-experienced patients in the US. Clin Drug Investig. 2007; 27(7):443-52.

View in: PubMed

subject areas

Adult
Antiretroviral Therapy, Highly Active
CD4 Lymphocyte Count
Coronary Disease
Costs and Cost Analysis
Data Collection
Drug Combinations
HIV Infections
HIV Protease Inhibitors
Humans
Lopinavir
Male
Markov Chains
Models, Statistical
Pyrimidinones
Quality of Life
Quality-Adjusted Life Years
Ritonavir
Survival Analysis
United States
Viral Load

authors with profiles

Kit N. Simpson
Walter J. Jones